Industry News
Paradromics Begins Recruiting Patients for Connexus Speech-Restoration Trial
The Austin-based company is now enrolling participants at the University of Michigan and Massachusetts General Hospital for the Connect-One study, the first clinical trial of a fully implantable BCI designed to restore speech.